___________________ Opioid Stewardship in Multimorbidity: Balancing Pain, Function, and Polypharmacy
Clinical Strategies • Avoid initiating benzodiazepines in patients on chronic opioid therapy when possible. • For existing combinations, implement gradual benzodiazepine tapers using evidence-based protocols [10]. • Consider safer alternatives: buspirone for anxiety, trazodone or doxepin for insomnia, cognitive- behavioral therapy for both conditions. • When tapering is not feasible, maximize harm reduction: prescribe naloxone, reduce opioid doses, increase monitoring frequency. • Document informed consent discussions about overdose risk. OPIOIDS AND SSRIs/SNRIs The interaction between opioids and serotonergic antidepres- sants involves multiple pathways. Most clinically significant is serotonin syndrome risk, particularly with tramadol, meperi- dine, and methadone, which have serotonergic properties [11]. Selective serotonin reuptake inhibitors (SSRIs) and serotonin- norepinephrine reuptake inhibitors (SNRIs) increase synaptic serotonin, and when combined with serotonergic opioids, can precipitate a potentially life-threatening syndrome char- acterized by altered mental status, autonomic instability, and neuromuscular abnormalities [12]. Additionally, many SSRIs and SNRIs inhibit cytochrome P450 enzymes (particularly CYP2D6 and CYP3A4) affecting opioid metabolism. For prodrug opioids like codeine and tramadol, which require CYP2D6 conversion to active metabolites, SSRI co-administration may reduce analgesic efficacy [13]. Conversely, CYP3A4 inhibition can increase levels of fentanyl, oxycodone, and methadone, raising toxicity risk [14]. Clinical Strategies • Assess depression and anxiety in all patients with chronic pain, as these conditions are highly comorbid. • Avoid tramadol, meperidine, and tapentadol in patients on SSRIs or SNRIs. • When serotonergic agents are necessary, choose opioids without serotonergic activity (e.g., morphine, hydromorphone, oxycodone). • Monitor for serotonin syndrome symptoms (e.g., agitation, confusion, rapid heart rate, dilated pupils, tremor, muscle rigidity) • Educate patients about over-the-counter medications with serotonergic properties (e.g., dextromethorphan, St. John’s wort)
ALTERNATIVES TO OPIOIDS IN MULTIMORBID PATIENTS
The American Geriatrics Society Beers Criteria recommend avoiding opioids when non-opioid alternatives can provide adequate pain control in older adults [15]. For multimorbid patients, this guidance becomes even more critical, as alterna- tives often address multiple conditions simultaneously. NON-OPIOID PHARMA-COLOGICAL OPTIONS Acetaminophen Acetaminophen remains a first-line analgesic for musculo- skeletal pain, with good safety profiles in most multimorbid patients. Maximum daily dosing should be reduced to 3 grams (rather than 4 grams) in older adults, those with hepatic impair- ment, or chronic alcohol use [16]. For patients on multiple medications, verify that acetaminophen is not duplicated in combination products. Topical NSAIDs Topical NSAIDs such as diclofenac gel and lidocaine patches offer localized pain relief with minimal systemic absorption, making them ideal for patients with cardiovascular or renal disease where oral NSAIDs pose risks [17]. Topical agents avoid most drug-drug interactions while providing efficacy comparable to oral analgesics for focal joint pain. Duloxetine Duloxetine, an SNRI approved for diabetic neuropathy, fibromyalgia, and musculoskeletal pain, simultaneously treats chronic pain and comorbid depression or anxiety [18]. This dual mechanism makes duloxetine particularly valuable in multimorbidity, addressing multiple conditions with a single agent. Monitor for serotonin syndrome when initiating in patients on other serotonergic medications. Anticonvulsants Anticonvulsants like gabapentin and pregabalin effectively treat neuropathic pain but require careful dose titration and renal dose adjustment. While safer than opioid monotherapy, their sedation profile necessitates caution in older adults at fall risk [19]. NONPHARMACOLOGICAL INTERVENTIONS Evidence increasingly supports multimodal approaches incorporating physical therapy, cognitive behavioral therapy, exercise, acupuncture, and mindfulness-based stress reduc- tion [20]. For multimorbid patients, these interventions offer pain relief without adding to polypharmacy burdens. Physical therapy improves both pain and function—a dual benefit particularly relevant when functional goals supersede pain elimination. Cognitive-behavioral therapy for pain reduces pain catastrophizing and improves coping strategies, with effects sustained long-term [21].
15
EliteLearning.com/Physician
Powered by FlippingBook